If granted, QRX003 could be approved for sale and reimbursement in Saudi Arabia as a treatment for Netherton Syndrome in 2H 2026
QRX003 could become the first ever approved treatment for Netherton Sy...
MONTGOMERYVILLE, Pa., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Teledyne Judson Technologies, a Teledyne Technologies [NYSE: TDY] company and global leader of advanced imaging solutions, announces the launch ...
Coverage unlocks reimbursable AI plaque quantification, advancing coronary risk assessment in everyday cardiology practice
Highlights
New permanent Category I CPT code 75577 for AI-enabled coronar...